Cargando…
The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD)
Since 2004, fish oil based lipid emulsions have been used in the treatment of intestinal failure associated liver disease, with a noticeable impact on decreasing the incidence of morbidity and mortality of this often fatal condition. With this new therapy, however, different approaches have emerged...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546610/ https://www.ncbi.nlm.nih.gov/pubmed/23363993 http://dx.doi.org/10.3390/nu4121828 |
_version_ | 1782256072743976960 |
---|---|
author | Chang, Melissa I. Puder, Mark Gura, Kathleen M. |
author_facet | Chang, Melissa I. Puder, Mark Gura, Kathleen M. |
author_sort | Chang, Melissa I. |
collection | PubMed |
description | Since 2004, fish oil based lipid emulsions have been used in the treatment of intestinal failure associated liver disease, with a noticeable impact on decreasing the incidence of morbidity and mortality of this often fatal condition. With this new therapy, however, different approaches have emerged as well as concerns about potential risks with using fish oil as a monotherapy. This review will discuss the experience to date with this lipid emulsion along with the rational for its use, controversies and concerns. |
format | Online Article Text |
id | pubmed-3546610 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-35466102013-01-23 The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD) Chang, Melissa I. Puder, Mark Gura, Kathleen M. Nutrients Review Since 2004, fish oil based lipid emulsions have been used in the treatment of intestinal failure associated liver disease, with a noticeable impact on decreasing the incidence of morbidity and mortality of this often fatal condition. With this new therapy, however, different approaches have emerged as well as concerns about potential risks with using fish oil as a monotherapy. This review will discuss the experience to date with this lipid emulsion along with the rational for its use, controversies and concerns. MDPI 2012-11-27 /pmc/articles/PMC3546610/ /pubmed/23363993 http://dx.doi.org/10.3390/nu4121828 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Chang, Melissa I. Puder, Mark Gura, Kathleen M. The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD) |
title | The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD) |
title_full | The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD) |
title_fullStr | The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD) |
title_full_unstemmed | The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD) |
title_short | The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD) |
title_sort | use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (ifald) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546610/ https://www.ncbi.nlm.nih.gov/pubmed/23363993 http://dx.doi.org/10.3390/nu4121828 |
work_keys_str_mv | AT changmelissai theuseoffishoillipidemulsioninthetreatmentofintestinalfailureassociatedliverdiseaseifald AT pudermark theuseoffishoillipidemulsioninthetreatmentofintestinalfailureassociatedliverdiseaseifald AT gurakathleenm theuseoffishoillipidemulsioninthetreatmentofintestinalfailureassociatedliverdiseaseifald AT changmelissai useoffishoillipidemulsioninthetreatmentofintestinalfailureassociatedliverdiseaseifald AT pudermark useoffishoillipidemulsioninthetreatmentofintestinalfailureassociatedliverdiseaseifald AT gurakathleenm useoffishoillipidemulsioninthetreatmentofintestinalfailureassociatedliverdiseaseifald |